drugset / Trial / NCT03351322
ENERGI-F701 for Female Hair Loss Treatment
Phase 2
Completed
67 enrolled
Energenesis Biomedical Co., Ltd.
A2 Healthcare Taiwan Corporation · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to evaluate the efficacy and safety of ENERGI-F701 Solution in female subjects with hair loss.
Timeline
- Start
- 2018-05-23
- Primary completion
- 2019-11-29
- Completion
- 2019-12-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ENERGI-F701 | Unknown | 1 ml | Topical |
| Comparator | Regaine | Unknown | 1 ml | Topical |